Here is the deal, kiddies. Over the YTD period PFE has gained enough that if it occurred over a year it would be super performance. The way it works is nothing goes up forever. Bottom line, there is nothing wrong with PFE. Good pipe line with about 100 drugs with 30 late stage. Good cash flow, about 10 Bil annually , good P/E, just a great solid investment.